Resiquimod
Tier C — Watch / tradeResiquimod
Targets:TLR7, TLR8
Indications (approved):Bladder cancer, Melanoma, Cutaneous T-cell lymphoma
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| CD-11301-001 | 86-95-3 | quinoline-2,4-diol |
| CD-11301-002 | 15151-57-2 | 3-nitroquinoline-2,4-diol |
| CD-11301-003 | 132521-66-5 | 2,4-dichloro-3-nitroquinoline |
| CD-11301-004 | 2854-16-2 | 1-amino-2-methylpropan-2-ol |
| CD-11301-005 | 33860-77-2 | 1-((2-chloro-3-nitroquinolin-4-yl)amino)-2-methylpropan-2-ol |
| CD-11301-006 | 133860-78-3 | 1-((3-amino-2-chloroquinolin-4-yl)amino)-2-methylpropan-2-ol |
| CD-11301-007 | 14077-58-8 | 2-ethoxyacetyl chloride |
| CD-11301-008 | 253120-65-9 | N-(2-chloro-4-((2-hydroxy-2-methylpropyl)amino)quinolin-3-yl)-2-ethoxyacetamide |
| CD-11301-009 | 558-30-5 | 2,2-dimethyloxirane |
Frequently asked questions
What are the approved indications of Resiquimod?
Approved indications include: Bladder cancer, Melanoma, Cutaneous T-cell lymphoma.
When does the Resiquimod patent expire?
No public expiry year is available for Resiquimod yet; this page updates once verified.
How many synthesis routes are recorded for Resiquimod?
1 synthesis routes are recorded; the shortest is 7 steps with 1.5 g (CD-11301) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Resiquimod intermediates?
All intermediates in Resiquimod routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Resiquimod intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21